(Q48116100)

English

Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Masafumi Harada

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

Masako M Taki

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

Ayumi Nose

3

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

Hitoshi Kubo

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

Kenji Mori

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

Hiromu Nishitani

6

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

Tsuyoshi Matsuda

7

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

language of work or name

0 references

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

Journal of Autism and Developmental Disorders

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

41

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

447-454

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

https://scigraph.springernature.com/pub.10.1007/s10803-010-1065-0

0 references

Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

N-acetylaspartate in the vertebrate brain: metabolism and function

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Histoanatomic observations of the brain in early infantile autism.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Measurement of GABA and contaminants in gray and white matter in human brain in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

In vivo detection of gray and white matter differences in GABA concentration in the human brain.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: an update

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

GABA(A) receptor downregulation in brains of subjects with autism

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Gray and white matter brain chemistry in young children with autism

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Regional brain chemical alterations in young children with autism spectrum disorder

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

[3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Neuronal impairment of adult moyamoya disease detected by quantified proton MRS and comparison with cerebral perfusion by SPECT with tc-99m HM-PAO: a trial of clinical quantification of metabolites.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Regional magnetic resonance spectroscopy of the brain in autistic individuals

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Neurochemical correlates of autistic disorder: a review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Proton magnetic resonance spectroscopic imaging of the brain in childhood autism

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Simultaneous in vivo spectral editing and water suppression

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Asperger syndrome: a proton magnetic resonance spectroscopy study of brain

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

GABA changes with vigabatrin in the developing human brain

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an 1H-MR spectroscopy study.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Increased serum levels of glutamate in adult patients with autism.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Direct in vivo measurement of human cerebral GABA concentration using MEGA-editing at 7 Tesla

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1065-0

21 January 2018

Measurement of variation in the human cerebral GABA level by in vivo MEGA-editing proton MR spectroscopy using a clinical 3 T instrument and its dependence on brain region and the female menstrual cycle

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma amino acid levels in children with autism and their families

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The neurobiology and genetics of infantile autism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/20652388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10803-010-1065-0

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/20652388

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48116100&oldid=2185600022"